Twist Bioscience CorporationTWSTNASDAQ
Loading
TWST Revenue Growth (YoY Quarterly)•+16.89%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+16.89%
+0.0pp
+25.99%
-7.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+3.24%
-0.9pp
+3.24%
-0.9pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +24.08% | +23.23% | +17.91% | +16.88% | +16.89% |
| Gross Profit Growth | +47.92% | +49.04% | +45.44% | +32.97% | +25.99% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.90% | +3.24% | +3.18% | +4.15% | +3.24% |
| Weighted Average Shares Diluted Growth | +2.90% | +3.24% | +5.19% | +4.15% | +3.24% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +7.55% | +34.66% | +51.13% | +64.22% | +27.34% |
| Inventory Growth | -23.80% | -31.33% | -8.94% | +17.57% | +39.99% |
| Asset Growth | -16.95% | -15.26% | +0.86% | +4.48% | +4.85% |
| Book Value per Share Growth | -24.90% | -23.89% | -5.64% | -3.93% | -3.11% |
| Debt Growth | -10.08% | -10.21% | -10.36% | +61.51% | +122.55% |
| R&D Expense Growth | -7.76% | -0.96% | -19.68% | -19.49% | -19.60% |
| SG&A Expenses Growth | +6.32% | +14.47% | +11.58% | +19.97% | +24.15% |
1 / 4